Sai Life Sciences Ltd

544306

Summary

Fair Value Assessment
Undervalued (5% Discount)
Fair ValueQ740.77UncertaintyVery High
Close Price697.05Mar 12, 2025
Market Closed
699.90
Price Up by 2.85 | 0.41 %
Previous Close
697.05
Day Range
689.95 – 707.50
Year Range
639.60 – 808.20
Bid / Ask
Market Cap
145.6 Bil
Volume / Average
8.3 k / 162.7 k
Beta
Shares Outstanding
208.10 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both (a) discovery/contract research (CRO) and (b) chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing.
Contact
Gachibowli Miyapur Road L4- 01 & 02, SLN Terminus Survey, Survey no. 133, Hyderabad, TG 500032
T +91 4068156000
www.sailife.com opens in a new tab
Sector
Healthcare
Industry
Diagnostics & Research
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees

Key Metrics

Income Statement (in Bil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
15.58 14.69 11.97 8.69
Revenue Growth %
22.71% 37.72%
Gross Profit
10.92 9.79 7.35 5.76
Gross Profit Margin %
70.10% 66.65% 61.45% 66.27%
Operating Income
2.56 1.81 0.77 0.35
Operating Margin %
16.42% 12.33% 6.42% 4.08%
EBIT
2.58 1.82 0.83 0.52
EBIT Margin %
16.53% 12.36% 6.92% 6.01%
EBITDA
3.90 3.01 1.82 1.42
EBITDA Margin %
25.01% 20.49% 15.22% 16.38%
Net Income
1.38 0.83 0.10 0.06
Net Profit Margin %
8.86% 5.64% 0.83% 0.72%
Basic EPS
7.10 3.98 0.48 0.30
Diluted EPS
7.01 3.98 0.48 0.30
Normalized EPS
3.90
Total Dividends per Share
Balance Sheet (in Bil, except ratios)
03/31/2024
03/2024
03/2023
03/2022
03/2020
Total Assets
22.75 22.75 21.87 21.64
Total Liabilities
13.00 13.00 12.99 12.86
Total Debt
9.28 9.28 9.32 9.65
Total Equity
9.75 9.75 8.88 8.79
Cash And Cash Equivalents
0.24 0.24 0.70 1.16
Working Capital
2.05 2.05 2.05 2.31
Shares Outstanding (Bil)
Book Value Per Share
Total Debt To Equity
0.95 0.95 1.05 1.10
Cash Flow Statement (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
2.43 2.63 2.19 1.05
Cash From Investing Activities
-2.14 -1.92 -1.02 -1.04
Cash From Financing Activities
-0.04 -0.95 -2.01 0.72
Capital Expenditures
1.82 1.13 2.07
Free Cash Flow
0.34 -0.07 -1.28
Change in Cash
0.25 -0.25 -0.83 0.73

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

Name
% Total
Shares Held
% Total
Assets
Trend
Prev. 8 Qtrs
Change Amount
Change %
Date
HBM Healthcare Investments AG Ord 1.99 1.94 4,140,124
4,140,124
––
Dec 31, 2024
GS India Equity I Inc USD 1.33 0.41 2,769,405
108,541
4.08%
Jan 31, 2025
Nippon India Small Cap Gr 1.22 0.34 2,531,180
Feb 28, 2025
American Funds SMALLCAP World A 1.17 0.03 2,426,120
2,426,120
––
Dec 31, 2024
Invesco India large& mid cap Gr 1.02 2.47 2,120,957
Feb 28, 2025
Total (for Top 5) 6.73 13,987,786
6,674,785

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top